The latest quarterly R&D expense is $96.57 Million with a QoQ Growth of +2.56%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $96.57M.
$96.57M
$96.57 Million
+2.56%
vs. $94.16M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $96.57M | +2.56% | +26.89% |
| Q1 FY2026Period end 2026-03-31 | $94.16M | +3.91% | +35.94% |
| Q4 FY2025Period end 2025-12-31 | $90.62M | +9.12% | +47.40% |
| Q3 FY2025Period end 2025-09-30 | $83.05M | +9.13% | +43.12% |
| Q2 FY2025Period end 2025-06-30 | $76.10M | +9.87% | -47.85% |
| Q1 FY2025Period end 2025-03-31 | $69.27M | +12.67% | +34.74% |
| Q4 FY2024Period end 2024-12-31 | $61.48M | +5.94% | +26.12% |
| Q3 FY2024Period end 2024-09-30 | $58.03M | -60.24% | +22.45% |
| Q2 FY2024Period end 2024-06-30 | $145.93M | +183.88% | +220.04% |
| Q1 FY2024Period end 2024-03-31 | $51.41M | +5.46% | +17.46% |
| Q4 FY2023Period end 2023-12-31 | $48.74M | +2.86% | +14.85% |
| Q3 FY2023Period end 2023-09-30 | $47.39M | +3.93% | N/A |
| Q2 FY2023Period end 2023-06-30 | $45.60M | +4.19% | N/A |
| Q1 FY2023Period end 2023-03-31 | $43.77M | +3.12% | N/A |
| Q4 FY2022Period end 2022-12-31 | $42.44M | N/A | N/A |
| Q4 FY2021Period end 2021-12-31 | $36.28M | -43.55% | +38.65% |
| Q3 FY2021Period end 2021-09-30 | $64.28M | +113.96% | +44.50% |
| Q2 FY2021Period end 2021-06-30 | $30.04M | 0.00% | +44.71% |
| Q1 FY2021Period end 2021-03-31 | $30.04M | +14.80% | +44.71% |
| Q4 FY2020Period end 2020-12-31 | $26.17M | -41.17% | N/A |
| Q3 FY2020Period end 2020-09-30 | $44.48M | +114.27% | N/A |
| Q2 FY2020Period end 2020-06-30 | $20.76M | 0.00% | N/A |
| Q1 FY2020Period end 2020-03-31 | $20.76M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
